Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Holders of 5% or more of RANI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Rani Therapeutics Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G | 8.79%4.31M shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Rani Therapeutics Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20259:02 PM ET | Armistice Capital, LLCand 1 other | 13G | 8.79%4.31M shares | New | Jun 30, 2025 | SEC |
| Jul 23, 20254:05 PM ET | Orca Capital AG | 13G/A | 4.30%1.89M shares | −5.60 ppfrom 9.90%Below 5% | Jul 22, 2025 | SEC |
| Jul 17, 20254:56 PM ET | Orca Capital AG | 13G | 9.90%4.35M shares | New | Jul 14, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Rani Therapeutics Holdings, Inc. shares.
No Form 144 notices for Rani Therapeutics Holdings, Inc. are on file.